Bioactivity | MAO-B-IN-16 is a selective monoamine oxidase B (MAO-B) inhibitor, with an IC50 of 1.55 µM. MAO-B-IN-16 can be used in the study of central nervous disorders, such as parkinson's disease[1]. |
Invitro | MAO-B-IN-16 (compound 4h) (10 μM; 24 h) has no cytotoxic effect on human neuroblastoma cells[1]. Cell Viability Assay[1] Cell Line: |
Name | MAO-B-IN-16 |
CAS | 1021238-13-0 |
Formula | C18H19NO3 |
Molar Mass | 297.35 |
Transport | Room temperature in continental US; may vary elsewhere. |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Reference | [1]. Yamada M, et al. Design, Synthesis, and Monoamine Oxidase B Selective Inhibitory Activity of N-Arylated Heliamine Analogues. ACS Medicinal Chemistry Letters, 2022. |